Live feed
Filing
SC 13G
SC 13G0001580642-24-000979·Celldex Therapeutics, Inc.
Schedule 13G ownership disclosure
Celldex Therapeutics Inc
Security class unavailable · CUSIP: 15117B202
Event date: 2023-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,630,013
- Percent of class
- 6.6400%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001580642-24-000979
- Form type
- SC 13G
- Filer
- Celldex Therapeutics, Inc.
- CIK
- CIK 744218
- Filed
- Feb 14, 2024
- Reporting period
- Dec 31, 2023
- Description
- Schedule 13G beneficial ownership